EFG Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

EFG Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$603K	Sell
2023 Q4	$4.65M	Sell
2023 Q3	$3.75M	Buy
2023 Q2	$4.21M	Sell
2023 Q1	$4.3M	Buy
2022 Q4	$3.81M	Buy
2022 Q3	$5.52M	Buy
2022 Q2	$4.86M	Buy
2022 Q1	$4.78M	Buy